Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126591492 | 12659149 | 2 | F | 201608 | 20160823 | 20160817 | 20160831 | EXP | US-PFIZER INC-2016384048 | PFIZER | 51.00 | YR | F | Y | 61.22000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126591492 | 12659149 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, SINGLE (ONE DOSE ONLY) | Y | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||
126591492 | 12659149 | 2 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
126591492 | 12659149 | 3 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
126591492 | 12659149 | 4 | C | ALEVE | NAPROXEN SODIUM | 1 | Oral | UNK (THREE TABLETS BY MOUTH OVER THE LAST TWO WEEKS) | 0 | TABLET | |||||||||
126591492 | 12659149 | 5 | C | ADVIL | IBUPROFEN | 1 | Oral | UNK, (ONE TABLET BY MOUTH, HAS TAKEN ABOUT 3 TABLETS OVER THE LAST TWO WEEKS) | 0 | TABLET | |||||||||
126591492 | 12659149 | 6 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Oral | 5 MG, AS NEEDED | 0 | 5 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126591492 | 12659149 | 1 | Hot flush |
126591492 | 12659149 | 2 | Hypertension |
126591492 | 12659149 | 3 | Barrett's oesophagus |
126591492 | 12659149 | 4 | Back pain |
126591492 | 12659149 | 5 | Headache |
126591492 | 12659149 | 6 | Back disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126591492 | 12659149 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126591492 | 12659149 | Abnormal dreams | |
126591492 | 12659149 | Asthenia | |
126591492 | 12659149 | Condition aggravated | |
126591492 | 12659149 | Decreased appetite | |
126591492 | 12659149 | Dizziness | |
126591492 | 12659149 | Dyskinesia | |
126591492 | 12659149 | Eating disorder | |
126591492 | 12659149 | Head discomfort | |
126591492 | 12659149 | Heart rate increased | |
126591492 | 12659149 | Insomnia | |
126591492 | 12659149 | Limb discomfort | |
126591492 | 12659149 | Loss of consciousness | |
126591492 | 12659149 | Musculoskeletal disorder | |
126591492 | 12659149 | Mydriasis | |
126591492 | 12659149 | Nausea | |
126591492 | 12659149 | Nervous system disorder | |
126591492 | 12659149 | Off label use | |
126591492 | 12659149 | Paraesthesia | |
126591492 | 12659149 | Tremor | |
126591492 | 12659149 | Vision blurred | |
126591492 | 12659149 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126591492 | 12659149 | 1 | 20160808 | 20160808 | 0 | |
126591492 | 12659149 | 3 | 2006 | 0 | ||
126591492 | 12659149 | 4 | 2015 | 0 | ||
126591492 | 12659149 | 6 | 201606 | 0 |